Partial Remission of advanced Melanoma by Combination Therapy with Nivolumab and Trametinib after Treatment Failure with Ipilimumab plus Nivolumab

被引：0
|
作者：
Zaremba, A. [1 ]
Chorti, E. [1 ]
Jockenhoefer, F. [1 ]
Albrecht, M. [1 ]
Placke, J. M. [1 ]
Knispel, S. [1 ]
Schadendorf, D. [1 ]
Hadaschik, E. [1 ]
Roesch, A. [1 ]
Ugurel, S. [1 ]
Zimmer, L. [1 ]
Livingstone, E. [1 ]
机构：
[1] Univ Klinikum Essen, Dermatol, Essen, Germany
来源：
JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT | 2018年 / 16卷
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
P37
引用
收藏
页码：38 / 38
页数：1
相关论文
共 50 条
  • [41] The best dosage of nivolumab plus ipilimumab combination for melanoma brain metastases
    Fukumoto, Takeshi
    Horita, Nobuyuki
    TRANSLATIONAL ONCOLOGY, 2022, 22
  • [42] COST-EFFECTIVENESS OF NIVOLUMAB plus IPILIMUMAB IN FIRST -LINE TREATMENT OF ADVANCED MELANOMA
    Baker, T. M.
    Paly, V. F.
    Sabater, J.
    Okoro, T.
    Kotapati, S.
    Briggs, A.
    VALUE IN HEALTH, 2016, 19 (07) : A730 - A730
  • [43] Treatment-Free Survival After Nivolumab vs Pembrolizumab vs Nivolumab-Ipilimumab for Advanced Melanoma
    Gupta, Mehul
    Stukalin, Igor
    Meyers, Daniel
    Goutam, Sid
    Heng, Daniel Y. C.
    Cheng, Tina
    Monzon, Jose
    Navani, Vishal
    JAMA NETWORK OPEN, 2023, 6 (06) : E2319607
  • [44] Bronchiolitis after Combination Immunotherapy With Ipilimumab and Nivolumab in a Melanoma Patient
    Basir, Shahir
    Bosiers, Jana
    Westgeest, Hans M.
    Yick, David C. Y.
    van Werven, Jochem R.
    van der Leest, Cor H.
    JOURNAL OF IMMUNOTHERAPY, 2024, 47 (07) : 263 - 265
  • [45] Pooled Long-Term Outcomes With Nivolumab Plus Ipilimumab or Nivolumab Alone in Patients With Advanced Melanoma
    Long, Georgina V.
    Larkin, James
    Schadendorf, Dirk
    Grob, Jean-Jacques
    Lao, Christopher D.
    Marquez-Rodas, Ivan
    Wagstaff, John
    Lebbe, Celeste
    Pigozzo, Jacopo
    Robert, Caroline
    Ascierto, Paolo A.
    Atkinson, Victoria
    Postow, Michael A.
    Atkins, Michael B.
    Sznol, Mario
    Callahan, Margaret K.
    Topalian, Suzanne L.
    Sosman, Jeffrey A.
    Kotapati, Srividya
    Thakkar, Pratik K.
    Ritchings, Corey
    Benito, Melanie Pe
    Re, Sandra
    Soleymani, Samira
    Hodi, F. Stephen
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (08)
  • [46] Nivolumab plus ipilimumab in melanoma brain metastases
    Giacomo, Anna Maria Di
    Maio, Michele
    LANCET ONCOLOGY, 2022, 23 (02): : E53 - E53
  • [47] Safety and Efficacy Implications of Discontinuing Combination Ipilimumab and Nivolumab in Advanced Melanoma
    Carlino, Matteo S.
    Sandhu, Shahneen
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (34) : 3792 - 3793
  • [48] Combination immune checkpoint blockade with ipilimumab and nivolumab in the management of advanced melanoma
    Spain, Lavinia
    Larkin, James
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2016, 16 (03) : 389 - 396
  • [49] Experience with nivolumab plus ipilimumab combination therapy for recurrent vaginal malignant melanoma: A case report
    Yano, Mitsutake
    Tonai, Nobutomo
    Kai, Kentaro
    Nasu, Kaei
    Kawano, Yasushi
    JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 2021, 148 : 8 - 8
  • [50] Ipilimumab Combined with Nivolumab: A Standard of Care for the Treatment of Advanced Melanoma?
    Carlino, Matteo S.
    Long, Georgina V.
    CLINICAL CANCER RESEARCH, 2016, 22 (16) : 3992 - 3998
12345